Future of Medicine Online
ICO dates
Start date: 2019-02-06
End date:
Registrated in: UK
Platform: STRATIS
Type: STRATIS
PREMIUM ICO
KYC passing required No |
Whitelist Yes |
Restriction for countries
No
Price | 1 MEDI = 0.1 USD |
MediConnect search trends in Google
MediConnect Roadmap
Q1 2018
Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database.
Q2 2018
Agreed blockchain platform partnership with Stratis.
Q3 2018
Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee.
Q4 2018
Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction.
Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect.
Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.
Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect.
Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.
Q1 2019
ICO Public Sale.
PDA Working Group meeting β Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.
PDA Working Group meeting β Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.
Q2 2019
Commence contract with the ASC to support the Nottingham Trial and UK roll out programme.
Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect.
6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.
Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect.
6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.
Q3 2019
Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester.
Partnership with Pharmacy Wholesaler β implementation of drug recall and counterfeit medication system.
Partnership with Pharmacy Wholesaler β implementation of drug recall and counterfeit medication system.
Q4 2019
Publish trial research and outcomes β present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.
Q1 2020
The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.
Q2 2020
Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.
Q3 2020
Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.
Q4 2020
The ASC achieves itβs goal of UK Pharmacies required to be members of the ASC and the MediConnect platform is used by all UK pharmacies
Director
Superintendent Pharmacist
PHZ Group Owner & Visionary
UK Meds Owner and Healthcare Visionary